Factors affecting response of chemotherapy in women with ovarian cancer

被引：0
|
作者：
Lubin, J. [1 ]
Markowska, A. [2 ]
Knapp, P. [3 ]
机构：
[1] Clin Oncol Poznan, Dept Gynecol, Poznan, Poland
[2] Inst Gynecol & Obstet, Poznan, Poland
[3] Univ Hosp Bialystok, Dept Gynecol, Bialystok, Poland
来源：
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | 2012年 / 33卷 / 06期
关键词：
Ovarian cancer; Chemotherapy; Factors affecting chemotherapy; MULTIDRUG-RESISTANCE GENE; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PRODUCT P-GLYCOPROTEIN; PACLITAXEL RESISTANCE; PROTEIN LRP; E-CADHERIN; EXPRESSION; CLUSTERIN; MDR1; CYCLOOXYGENASE-2;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Chemotherapy plays an important role in the treatment of ovarian cancer. Patients' response to chemotherapy is determined by a variety of acknowledged factors, but one might expect that many of them are yet to be described. The aim of this paper was to present the most essential yet still to be generally assessed in clinical practice, factors, which include: E-cadhedrin, hypoxia inducible factor alpha, survivin, COX-2, clusterin, BRCA1 protein, TP53 protein, YY1 protein, multidrug resistance protein, and interleukin-8.
引用
收藏
页码：644 / 647
页数：4
相关论文
共 50 条
  • [21] Pathological response of ovarian cancer to neoadjuvant chemotherapy
    Ivantsov, Alexandr O.
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (06)
  • [22] Prognosis and factors affecting colorectal cancer with ovarian metastasis
    Fangyue Zhou
    Jingxin Ding
    Updates in Surgery, 2021, 73 : 391 - 398
  • [23] Prognosis and factors affecting colorectal cancer with ovarian metastasis
    Zhou, Fangyue
    Ding, Jingxin
    UPDATES IN SURGERY, 2021, 73 (02) : 391 - 398
  • [24] Factors Affecting the Comprehension of Outpatients Receiving Cancer Chemotherapy
    Nishibe-Toyosato, Seira
    Ando, Yosuke
    Nakasuji, Nayu
    Hayashi, Takahiro
    Ito, Kaori
    Matsuda, Hidezo
    Tsujii, Naho
    Tsuge, Masahiro
    Imaizumi, Kazuyoshi
    Kawada, Kenji
    Yamada, Shigeki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2023, 46 (03) : 505 - 510
  • [25] Intraperitoneal chemotherapy in older women with epithelial ovarian cancer
    O'Cearbhaill, Roisin
    Li, Daneng
    Shi, Weiji
    Thaler, Howard
    Sabbatini, Paul J.
    Konner, Jason
    Hensley, Martee L.
    Aghajanian, Carol A.
    Lichtman, Stuart M.
    Tew, William P.
    JOURNAL OF GERIATRIC ONCOLOGY, 2012, 3 (03) : 189 - 195
  • [26] Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer
    Naumann, R. Wendel
    Sukumvanich, Paniti
    Edwards, Robert P.
    GYNECOLOGIC ONCOLOGY, 2009, 114 (01) : 37 - 41
  • [27] Factors Affecting Pathological Complete Response After Neoadjuvant Chemotherapy in Operable Primary Breast Cancer
    Lv, Yanli
    Li, Yi
    Mu, Weimin
    Fu, Hui
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2020, 30 (04): : 389 - 393
  • [28] Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer
    Naumann, R. W.
    Sukumvanich, P.
    Edwards, R. P.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S22 - S22
  • [29] Fertility preservation in endometriosis: Appraising the factors affecting the ovarian response
    Goaz, S.
    Fouks, Y.
    Azem, F.
    HUMAN REPRODUCTION, 2021, 36 : 276 - 276
  • [30] Continued Chemotherapy After Complete Response to Primary Therapy Among Women With Advanced Ovarian Cancer
    Hess, Lisa M.
    Rong, Nan
    Monahan, Patrick O.
    Gupta, Paridha
    Thomaskutty, Champ
    Matei, Daniela
    CANCER, 2010, 116 (22) : 5251 - 5260
12345